News - 2005 / 2006
Spring 2006 News
University of Chicago Faculty Members
Co-Organize, Chair, and Speak at 2006 FASEB Summer Research Conferences
 |
 |
The transplant
immunology 2006 FASEB Summer Research Conferences will
take place June 3-8, 2006 in Snowmass Village, Colorado. The
conference is co-organized by U of C faculty member Anita Chong
(Associate Professor, Transplact Srugery). Maria Alegre
(Assistant Professor, Rheumatology) will chair the session entitled "T
Cells, B Cells, and More!" and will give a talk on "T Cell Activation
in Alloimmunity". (The
Imprint, Spring 2006)
|
Ellen and Melvin Gordon Give $25M for
the Ellena and Melvin Gordon Center for Integrative Science

|
On April 26, the University of
Chicago officially opened its largest
science building and announced that Ellen and Melvin Gordon, who
operate Tootsie Roll Industries, Inc., have donated $25 million to name
the building. The Ellen and Melvin Gordon Center for Integrative
Science houses scientists in the Divisions of the Biological Sciences
and the Physical Sciences, allowing them to pursue innovative research
that crosses traditional boundaries between physics, chemistry, and
biology. (The
University of Chicago Legacy, Volume 18, The Forefront,
May/June 2006, The
University of Chicago Chronicle, Vol. 25 No. 15, Peer
Review Spring 2006).
|
CIS to house shared-use facilities for
University and Argonne scientists

|
Three new high-tech facilities in the Center for
Integrative Science
will augment the University’s research in a range of projects that
include the fabrication of nanostructures, studying how catalysts drive
chemical reactions and probing conditions inside various parts of a
cell.
The facilities will be equipped with an array of new research
instruments: a scanning electron microscope, an electron paramagnetic
resonance instrument, and a time-resolved luminescence spectrometer and
microscope, which will be available for use by University and Argonne
scientists. Scientists at the University and Argonne already share the
Enrico Fermi Institute’s electron microprobe facility, which has been
operating for about one year. University scientists use the microprobe
to study the chemical composition of meteorites and other materials (The University
of Chicago Chronicle, March 2006).
|
Barbara Kee awarded the 2006 AAI
Cynthia Chambers Memorial-EBioscience Junior Faculty Award
 |
Dr.
Kee's research investigates the role of transcription factors of the E2
family in lymphocyte development and carcinogenesis. The AAI award
honors the memory of Dr. Cynthia Chambers and was established to
advance the career of junior scientists, specifically in the area of
cancer biology. Dr. Kee will present her research at the next Annual
Meeting of the American Association of Immunolgists, held May 12-16,
2006 in Boston, MA.
|
Gwen and Jules Knapp Give $25M for the
Gwen and Jules Knapp Center for Biomedical Discovery
 |
In February, longstanding University of Chicago
friends and
philanthropists, Gwen and Jules Knapp, donated $25 million to name the
Gwen and Jules Knapp Center for Biomedical Diversity. This gift
will not only help build the University's tallest research building, it
is also an example of the Knapps' continuing impact on science and
medicine at Chicago. (The
University of Chicago Legacy, Volume 18).
|
Katie Sawai, a COI graduate student in
the Aifantis lab, awarded a $1,000 scholarship to attend this year's "T
cell signaling and activation" Keystone meeting in Steamboat Springs,
Colorado
 |
Katie Sawai presented a poster
entitled "A unique role for cyclin D3 in early B cell development".
|
Winter 2006 News
The Aifantis laboratory reveals that Hedgehog
signaling regulates lymphocyte progenitor development in the thymus
Raymond Roos elected to Johns Hopkins
University Society of Scholars

|
Raymond Roos, M.D./Ph.D.,
professor and former chair of neurology, has been elected to the Johns
Hopkins University Society of Scholars as one of 15 esteemed scientists
and clinicians honored during the society's 37th induction
ceremony. Roos is a nationally recognized researcher and leading
clinician in the field of neurodegenerative disorders, particularly
amyotrophic lateral sclerosis, multiple sclerosis and prion diseases. (Medicine on the
Midway, Winter 2006)
|
University of Chicago researchers make strides
in diabetes study

|
Recent attempts to manipulate
the immune system of mice that have Type I diabetes have shown measured
success. In three seperate studies at the University of Chicago,
Harvard and Washington University in St. Louis, researchers
successfully reversed Type I diabetes in 32 percent of 22 mice in the
experiments. However, the scientists found no evidence of
insulin-producing beta cells derived from donated spleen cells, which
initially had been thought to be a crucial component of therapy,
transplant immunologist Anita Chong said. The study offers hope
for reversal of the disease for recently diagnosed patients, but may
disappoint those who hoped to cure established diabetes by using stem
cells from donor spleens to help patients grow new pancreatic
islets. The three studies sought to confirm the results of a
high-profile 2003 study in which those hurdles appeared to have been
overcome. (Medicine
on the Midway, Winter 2006)
|
Autumn 2005 News
BSD Breaks Ground on the
Center for Biomedical Discovery
|
The groundbreaking ceremony
for the Center for
Biomedical Discovery (CBD) took place on October 17, 2005, marking an
exciting point in the timeline for construction of this new facililty.
The CBD will house research programs from the Departments of Medicine
and Pediatrics, the University of Chicago Cancer Research Center, the
Institute for Molecular Pediatric Science and the Ludwig Center for
Metastasis Research. Leaders of these programs are (pictured left to
right) Dr. Geoffrey Greene, Ph.D., Co-Director, Ludwig
Center for Metastasis Research, Dr. Michelle LeBeau, Ph.D., Director,
Cancer Research Center, Dr. Ralph Weichselbaum, M.D., Co-Director,
Ludwig Center for Metastasis Research, and Steven Goldstein, M.D.,
Ph.D., Chairman of Pediatrics and Director, Institute for Molecular
Research. |
Novel Approaches to Research
and Teaching
|
Before arriving at the
University of Chicago, Martin
Weigert, Ph.D.,
Professor of Pathology and Director of the Gwen Knapp Center for Lupus
and Immunology Research, was a faculty member in Princeton's Department
of Molecular Biology researching the molecular aspects of the immune
system. After dedicating so much time and effort to this field of
research, Weigert discovered that aspects of his work were becoming
more relevant to questions relating to autoimmune disease, and he began
working on lupus related problems such as the structure, regulation,
and genetic control of lupus-associated antibodies. (Peer
Review, Fall 2005) |
A
COI post-doctoral fellow, Luqiu Chen, is awarded an American Heart
Association fellowship
|
A
post-doctoral fellow in the Alegre lab, Luqiu Chen, was awarded an AHA
fellowship to continue a collaborative project between the Alegre and
Chong laboratories. Luqiu Chen studies the role of TLR signaling during
immune responses to transplanted organs.
|
COI graduate student Ruth
Taniguchi receives the Best Poster Award at the International Workshop
on NK cells and Innate Immunity in Hawaii, November 4-8, 2005
 |
Ruth
Taniguchi's thesis research in the Kumar laboratory focuses on the
function of the surface receptor 2B4 expressed at the surface of mouse
and human NK cells. Ruth is in her 3rd year of graduate studies in the
Committee on Immunology at the University of Chicago.
|
Choosing between death and
proliferation. The role of a Serine 194 in FADD, the death domain
containing adaptor and its regulator, the Casein Kinase is uncovered in
Marcus Peters' laboratory
 |
While
FADD is a well-established regulator of apoptosis mediated by Death
Receptors such as CD95 (APO-1/Fas), a number of studies have indicated
interferences with cell cycle and cell proliferation. The Peter lab has
now uncovered the role of Caseine Kinase Iα as regulator
of FADD
through phosphorylation of Serine 194. FADD and CKIα
colocalize on the
spindle poles in cell metaphase, representing a crucial event during
mitosis. This pathway also regulates the ability of Taxol to arrest
cells in mitosis, raising the possibility that compounds that activate
CKIα to increase FADD phosphorylation may act as
chemosensitizers for
cancer treatment (E.
Alapatt et al., Molecular Cell 2005, 19, 321-332)
|
Four new COI Faculty join the
University of Chicago: Drs. Erin Adams, David Boone, Sasha Chervonsky,
and Tanya Golovkina

|
Erin Adams, PhD, joins the Department of
Biochemistry and Molecular Biology
as an Assistant Professor. Erin trained at Stanford with Peter Parham
(graduate studies) and Chris Garcia (postdoctoral research). A
biochemist and crystallographer, she elucidated the first structure of
a TCRγδ bound to its ligand. |
 |
David
Boone, PhD, joins the Department of Medicine, Center for Inflammatory
Bowel Diseases as an Assistant Professor. David trained with Averil Ma
at the University of Chicago then at UC San Francisco and made major
contributions to the understanding of inflammation and NFß
regulation
in the intestinal mucosa through novel biochemical mechanisms of
ubiquitination. |
|
Sasha
Chervonsky, PhD, joins the Department of Pathology as an Associate
Professor with tenure. Sasha's laboratory studies the
development of Peyera's patches in the small bowel, the role of
endothelial
cells in
antigen presentation in autoimmune Type I Diabetes and the role of MHC
in central tolerance. |
 |
Tanya
Golovkina, PhD, joins the Department of Microbiology as an Associate
Professor with tenure. Tanya's laboratory studies models of
retroviral
induction of mammary tumors in mouse and has discovered entirely new
ways in which retroviruses manipulate the immune system. |
Bana Jabri promoted to the
rank of Associate Professor with Tenure
 |
Bana
Jabri MD, PhD, who joined the Faculty at the University of Chicago in
2002 as an Assistant Professor in the Department of Pathology with
secondary appointments in Pediatrics and Medicine, was promoted to the
rank of Associate Professor with tenure. Bana’s laboratory is
in the
Center for Inflammatory Bowel Diseases and studies Celiac Disease, a
human disease resulting from an aberrant immune response in the small
bowel to the gluten found in wheat. Her work has elucidated the
mechanism leading to the destruction of intestinal epithelial cells by
intraepithelial lymphocytes in patients with celiac disease. More
generally, her research demonstrates new elements of a cross talk
between the tissue and the immune system that regulates cytolytic
responses in the mucosal environment.
|
Summer 2005 News
Two University of Chicago
undergraduate students in COI labs receive HHMI award
|
Shayla
Hesse and Dustin Guzior, two University of Chicago undergraduate
students, received a Best Presentation Award from the Howard Hughes
Medical Institute Summer Research Program for their studies in COI
laboratories. Shayla Hesse has been working in the Alegre lab and
presented her
unexpected observation that reduced T cell NF-kB promotes the formation
of anti-nuclear antibodies in a mouse model of lupus. Dustin Guzior was
working in the Kumar lab, establishing a role for 2B4 in NK cell
self-tolerance.
|
|
|
|
Committee On Immunology
News Archive
|